Biotechnology News and Research

RSS
CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

16 Oct 2013
Evidence less consistent for high blood sugar, insulin treatment and oral agents

Evidence less consistent for high blood sugar, insulin treatment and oral agents

16 Oct 2013
Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

16 Oct 2013
Researchers develop new method to produce artificial membranes using nanoscaled tip

Researchers develop new method to produce artificial membranes using nanoscaled tip

16 Oct 2013
CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

15 Oct 2013
House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

15 Oct 2013
Astrazeneca Acquires Spirogen For Up To $440M

Astrazeneca Acquires Spirogen For Up To $440M

15 Oct 2013
State highlights: Md. submits plan to tie overhaul hospital charges to state's economy

State highlights: Md. submits plan to tie overhaul hospital charges to state's economy

15 Oct 2013
Teva gets FDA approval for generic version of TOBI in US

Teva gets FDA approval for generic version of TOBI in US

15 Oct 2013
First Edition: October 14, 2013

First Edition: October 14, 2013

14 Oct 2013
Genentech plans to invest over $285M for expansion of biologics manufacturing facilities

Genentech plans to invest over $285M for expansion of biologics manufacturing facilities

14 Oct 2013
Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

11 Oct 2013
Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

11 Oct 2013
Yale Launches Collaboration With ARO, CRO Partners

Yale Launches Collaboration With ARO, CRO Partners

11 Oct 2013
Auxilium Licenses Stendra From Vivus For Up To $300M

Auxilium Licenses Stendra From Vivus For Up To $300M

11 Oct 2013
ImmunoGen signs new license agreement with Novartis

ImmunoGen signs new license agreement with Novartis

11 Oct 2013
New gene transfer strategy effective for achieving persistent immunotherapy to treat tumors

New gene transfer strategy effective for achieving persistent immunotherapy to treat tumors

11 Oct 2013
FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

11 Oct 2013
People who live in coal mining regions face increased risk depression

People who live in coal mining regions face increased risk depression

11 Oct 2013
Diverse Neurological Disorders Appear To Share Tangled Metabolic Roots

Diverse Neurological Disorders Appear To Share Tangled Metabolic Roots

10 Oct 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback